Jones Hill Capital Lp Portfolio Stock Holdings
According to the SEC 13F filed on August 13, 2026, Jones Hill Capital Lp disclosed 29 stock positions valued at approximately $470.36M as of quarter-end June 30, 2026. The largest holdings include BIOMARIN PHARMACEUTICAL INC, GILEAD SCIENCES INC, and ARCUTIS BIOTHERAPEUTICS INC.
- Report Period
- June 30, 2026
- No. of Stocks
- 29
- Portfolio Value
- $470.36M
Holdings by Sector
Jones Hill Capital Lp Portfolio Holdings in Q2 2026
| Company | Symbol | Sector | Portfolio % | Shares | Change (Shares) | Change % | Value |
|---|---|---|---|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC | BMRN | Healthcare | 17.42% | 1,431,590 | +163,200 | +12.87% | $81,915,580 |
| GILEAD SCIENCES INC | GILD | Healthcare | 9.21% | 343,043 | +343,043 | +100.00% | $43,340,053 |
| ARCUTIS BIOTHERAPEUTICS INC | ARQT | Healthcare | 6.07% | 1,089,701 | +1,089,701 | +100.00% | $28,571,960 |
| MADRIGAL PHARMACEUTICALS INC | MDGL | Healthcare | 6.00% | 52,545 | +52,545 | +100.00% | $28,214,038 |
| BICARA THERAPEUTICS INC | BCAX | Other | 5.63% | 892,621 | -367,515 | -29.16% | $26,501,917 |
| RELMADA THERAPEUTICS INC | RLMD | Healthcare | 5.38% | 3,655,075 | +3,312,323 | +966.39% | $25,293,119 |
| TREVI THERAPEUTICS INC | TRVI | Healthcare | 5.31% | 1,339,212 | +969,037 | +261.78% | $24,976,304 |
| PHARVARIS N V | PHVS | Other | 4.98% | 677,879 | +510,865 | +305.88% | $23,441,056 |
| XENON PHARMACEUTICALS INC | XENE | Healthcare | 4.72% | 367,900 | +367,900 | +100.00% | $22,206,444 |
| ANI PHARMACEUTICALS INC | ANIP | Healthcare | 4.11% | 233,808 | -84,783 | -26.61% | $19,354,626 |
| IMMUNOCORE HLDGS PLC | IMCR | Healthcare | 3.46% | 512,856 | +512,856 | +100.00% | $16,283,178 |
| AMYLYX PHARMACEUTICALS INC | AMLX | Healthcare | 3.41% | 894,058 | -704,736 | -44.08% | $16,057,282 |
| INSMED INC | INSM | Healthcare | 2.77% | 122,375 | +122,375 | +100.00% | $13,047,622 |
| NUVALENT INC | NUVL | Healthcare | 2.58% | 98,442 | -202,388 | -67.28% | $12,157,587 |
| CAPRICOR THERAPEUTICS INC | CAPR | Healthcare | 2.15% | 420,751 | -488,456 | -53.72% | $10,131,684 |
| ACLARIS THERAPEUTICS INC | ACRS | Healthcare | 1.98% | 1,759,492 | +1,759,492 | +100.00% | $9,307,713 |
| IMMUNIC INC | IMUX | Other | 1.76% | 539,814 | +539,814 | +100.00% | $8,296,941 |
| ORIC PHARMACEUTICALS INC | ORIC | Healthcare | 1.72% | 747,313 | +747,313 | +100.00% | $8,093,400 |
| TONIX PHARMACEUTICALS HLDG C | TNXP | Other | 1.70% | 625,428 | +173,312 | +38.33% | $7,980,461 |
| SYNDAX PHARMACEUTICALS INC | SNDX | Healthcare | 1.58% | 340,000 | +340,000 | +100.00% | $7,432,400 |
| OLEMA PHARMACEUTICALS INC | OLMA | Healthcare | 1.53% | 574,166 | +574,166 | +100.00% | $7,182,817 |
| VIR BIOTECHNOLOGY INC | VIR | Healthcare | 1.43% | 659,213 | -539,000 | -44.98% | $6,717,380 |
| CORBUS PHARMACEUTICALS HLDGS | CRBP | Healthcare | 1.30% | 653,572 | +653,572 | +100.00% | $6,130,505 |
| DIANTHUS THERAPEUTICS INC | DNTH | Healthcare | 1.18% | 57,100 | +57,100 | +100.00% | $5,566,108 |
| VERTEX PHARMACEUTICALS INC | VRTX | Healthcare | 1.17% | 11,123 | -97,480 | -89.76% | $5,525,128 |
| ENLIVEN THERAPEUTICS INC | ELVN | Healthcare | 0.54% | 49,850 | -543,190 | -91.59% | $2,529,888 |
| STRUCTURE THERAPEUTICS INC | GPCR | Healthcare | 0.46% | 40,567 | -60,026 | -59.67% | $2,177,231 |
| PHATHOM PHARMACEUTICALS INC | PHAT | Healthcare | 0.37% | 161,486 | +161,486 | +100.00% | $1,752,123 |
| ACHIEVE LIFE SCIENCE INC | ACHV | Healthcare | 0.04% | 26,760 | +26,760 | +100.00% | $174,743 |
Showing 29 of 29 holdings in the latest reporting period.